Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
37,93 USD | +2,51% | -4,84% | +76,25% |
26/03 | SPYRE THERAPEUTICS, INC. : Stifel Nicolaus ontvangt een koopadvies | ZM |
01/03 | SPYRE THERAPEUTICS, INC. : Wells Fargo Securities positief over het aandeel | ZM |
Omzet 2024 * | 6,82 mln. 6,31 mln. | Omzet 2025 * | 5,17 mln. 4,79 mln. | Marktkapitalisatie | 1,37 mld. 1,27 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -169 mln. -157 mln. | Nettowinst (verlies) 2025 * | -167 mln. -155 mln. | EV/omzet 2024 * | 108 x |
Nettoliquiditeiten 2024 * | 638 mln. 591 mln. | Nettoliquiditeiten 2025 * | 333 mln. 309 mln. | EV/omzet 2025 * | 201 x |
K/w-verhouding 2024 * |
-10,3
x | K/w-verhouding 2025 * |
-12,8
x | Werknemers | 30 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 87,45% |
Recentste transcriptie over Spyre Therapeutics, Inc.
1 dag | +2,51% | ||
1 week | -4,84% | ||
Lopende maand | +38,23% | ||
1 maand | +45,33% | ||
3 maanden | +85,02% | ||
6 maanden | +230,98% | ||
Lopend jaar | +76,25% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Cameron Turtle
CEO | Chief Executive Officer | 34 | 22-06-23 |
Scott Burrows
DFI | Director of Finance/CFO | 47 | 01-09-23 |
Brian Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 27/11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tomas Kiselak
BRD | Director/Board Member | 38 | 22-06-23 |
Russell Cox
CHM | Chairman | 60 | 01-06-15 |
Jeffrey Albers
BRD | Director/Board Member | 51 | 27/11 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 37,93 | +2,51% | 951 529 |
27-03-24 | 37 | -1,62% | 573 502 |
26-03-24 | 37,61 | -2,26% | 327 872 |
25-03-24 | 38,48 | -6,60% | 456 371 |
22-03-24 | 41,2 | +3,36% | 302 065 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+76,25% | 1,37 mld. | |
+2,73% | 108 mld. | |
+9,59% | 103 mld. | |
+6,58% | 23,48 mld. | |
-12,59% | 21,93 mld. | |
-3,29% | 19,68 mld. | |
-35,36% | 18,37 mld. | |
-13,29% | 16,33 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,15 mld. |